IndustryIntelligence | Biological Products

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$57	Subscribers	2004	7% Convertible Note Due [2006]	Viragen, Inc.
$50	Subscribers	2004	7% Convertible Note Due [2006]	Viragen, Inc.
$32	Subscribers Preview	2003	Additional Funding Agreement	Bristol Investment Fund, Ltd.	Viragen, Inc.
$36	Subscribers Preview	2003	Additional Funding Agreement	Alpha Capital AG; Crescent International Ltd.	Palisades Equity Fund L.P.; Viragen
$32	Subscribers Preview	2003	Additional Funding Agreement	Bristol Investment Fund, Ltd.	Viragen, Inc.
$42	Subscribers Preview	2001	Agency Agreement	Immunex; Chase Manhattan	Wilmington Trust
$41	Subscribers Preview	2001	Calculation Agency Agreement	Abbott Labs; Amgen; Baxter Int'l	Bristol-Myers 2 3 4 5 6 2 3 4
$34	Subscribers Preview	2001	Calculation Agency Agreement	Abbott Labs; Amgen; Baxter Int'l	Bristol-Myers 2 3 4 5 6 2 3 4
$43	Subscribers Preview	2001	Calculation Agency Agreement	Amgen; Cisco Systems; Intel	Maxim 2 2 3 4
$42	Subscribers Preview	2001	Calculation Agency Agreement	Amgen; Cisco Systems; Intel	Maxim 2 2 3 4
$41	Subscribers Preview	2001	Calculation Agency Agreement	Amgen; Cisco Systems; Intel	Maxim 2 2 3 4
$38	Subscribers Preview	2007	Contribution Agreement	CytRx Corp.
$40	Subscribers Preview	2007	Contribution Agreement	CytRx Corp.
$43	Subscribers Preview	2004	Contribution Agreement	Hemosol LP; LPBP Inc.	Hemosol; MDS
$42	Subscribers Preview	2004	Contribution Agreement	Hemosol Inc.	MDS Inc.
$41	Subscribers Preview	2004	Contribution Agreement	Hemosol Inc.	MDS Inc.
$40	Subscribers Preview	2004	Contribution Agreement	Hemosol Inc.	MDS Inc.
$37	Subscribers	2006	Contribution Agreement	Paligent Inc.
$58	Subscribers Preview	2003	Convertible Debenture	Hemispherx; Interferon	Schulte Roth
$33	Subscribers	2001	Convertible Note	Alfacell Corp.